Evidence map›Paper›PMID 39403434›Full record

ArticleFrontiers in public health2024

Antibiotic susceptibility of

Abrar K Thabit, Ammar M Alghamdi, Musaab Y Miaji, Feras S Alharbi, Anas F Jawah, Fatimah Alturki, Nehal Hosin, Mohammed Bazuqamah, Masaad Saeed Almutairi, Hamad Alhamed and 8 more

Abstract readMulticenter Study
In one paragraph

Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Antibiotics Resistance Profile of Clinical Isolates ofAntibiotics (Basel, Switzerland) · 2025
    Article
  10. Article
  11. Harnessing phages to tackle antimicrobial resistance: a Saudi Arabian perspective.Frontiers in cellular and infection microbiology · 2025
    Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Abrar K ThabitDepartment of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Ammar M AlghamdiFaculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Musaab Y MiajiFaculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Feras S AlharbiFaculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Anas F JawahFaculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Fatimah AlturkiDepartment of Microbiology, King Fahad Hospital of the University, Dammam, Saudi Arabia.
Nehal HosinDepartment of Microbiology, College of Medicine, Imam Abdulrahman Bin Faisal University, Al Khobar, Saudi Arabia.
Mohammed BazuqamahDepartment of Microbiology, King Khaled Hospital, Najran, Saudi Arabia.
Masaad Saeed AlmutairiDepartment of Pharmacy Practice, College of Pharmacy, Qassim University, Qassim, Saudi Arabia.
Hamad AlhamedDepartment of Laboratory and Blood Bank, King Fahad Specialist Hospital, Qassim, Saudi Arabia.
Alaa ElhendawyDepartment of Microbiology, King Fahad Hospital, Al-Baha, Saudi Arabia.
Dalya AtallahDepartment of Clinical Microbiology, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
Abdulaziz A HumadiDepartment of Laboratory and Blood Bank, King Fahad Specialist Hospital, Tabuk, Saudi Arabia.
Khalid A AlfifiDepartment of Microbiology, King Fahad Specialist Hospital, Tabuk, Saudi Arabia.
Khadija AlfadelDepartment of Microbiology, Maternity and Children Hospital, King Salman Medical City, Madinah, Saudi Arabia.
Khalid EljaalyDepartment of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Mahmoud A ElfakyDepartment of Natural Products, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Saudi AntiMicrobial Surveillance (SAMS) study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: Between 2022 and 2023, isolates from various infection sites were collected from seven hospitals in seven different regions of Saudi Arabia. The isolates were shipped to an academic microbiology lab, where their susceptibility was tested by BMD following Clinical Laboratory Standards Institute guidelines using Sensititre GNX3F plates. %Susceptibility to each antibiotic, and MIC50 and MIC90 were determined. Results: In total, 185 Conclusion:

Indexed as

Anti-Bacterial AgentsMicrobial Sensitivity TestsPseudomonas aeruginosaPseudomonas InfectionsAdolescentAdultAgedCross InfectionDrug Resistance, Multiple, BacterialFemaleHumansMaleMiddle AgedSaudi ArabiaAnti-Bacterial Agentsantibioticsantimicrobial resistancebroth microdilutionPseudomonas aeruginosaSaudi Arabiasurveillance

Identifiers

PMID39403434
PMCPMC11471531

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.